On August 18, 2021, Beijing Leadman Biochemistry Co.,Ltd. closed the transaction. The company has paid an issuance expense CNY 5,768,773.34, bringing the net proceeds to CNY 550,831,226.98. The registered capital increased from 421,051,985 shares to 547,265,137 shares.